Loading data
PBINYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.89 bn USD | 2.03 bn USD | 2.08 bn USD | 2.48 bn USD | 3.67 bn USD |
| Cost of revenue | — | 964.3 m USD | 1.05 bn USD | — | — |
| Research and development expense | 15.28 m USD | 31.96 m USD | 29.49 m USD | 35.46 m USD | 46.78 m USD |
| Selling, general and administrative expense | 621.57 m USD | 717.89 m USD | 781.61 m USD | 785.55 m USD | 924.16 m USD |
| Interest expense | — | — | 100.45 m USD | 89.98 m USD | 96.89 m USD |
| Profit before tax | 192.52 m USD | -52.33 m USD | -43.92 m USD | 188.65 m USD | -7.42 m USD |
| Income tax expense | 47.83 m USD | -154.83 m USD | 17.35 m USD | 42.96 m USD | -10.92 m USD |
| Net income (reported basis) | 144.7 m USD | -203.6 m USD | -385.63 m USD | 36.94 m USD | -1.35 m USD |
| Net income attributable to common shareholders | — | -203.6 m USD | -385.63 m USD | 36.94 m USD | -1.35 m USD |
| Basic earnings per share | 0.84 USD/share | -1.13 USD/share | -2.2 USD/share | 0.21 USD/share | -0.01 USD/share |
| Diluted earnings per share | 0.84 USD/share | -1.12 USD/share | -2.2 USD/share | 0.21 USD/share | -0.01 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.